Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy
Yumi ParkHelena I Boshoff

Abstract

Mechanisms of magnesium homeostasis in Mycobacterium tuberculosis are poorly understood. Here, we describe the characterization of a pyrimidinetrione amide scaffold that disrupts magnesium homeostasis in the pathogen by direct binding to the CorA Mg2+/Co2+ transporter. Mutations in domains of CorA that are predicted to regulate the pore opening in response to Mg2+ ions conferred resistance to this scaffold. The pyrimidinetrione amides were cidal against the pathogen under both actively replicating and nonreplicating conditions in vitro and were efficacious against the organism during macrophage infection. However, the compound lacked efficacy in infected mice, possibly due to limited exposure. Our results indicate that inhibition of Mg2+ homeostasis by CorA is an attractive target for tuberculosis drug discovery and encourage identification of improved CorA inhibitors.

References

Mar 27, 2003·Molecular Microbiology·Christopher M SassettiEric J Rubin
May 31, 2003·Proceedings of the National Academy of Sciences of the United States of America·Gyanu LamichhaneWilliam R Bishai
May 25, 2006·Frontiers in Bioscience : a Journal and Virtual Library·Michael E Maguire
Mar 16, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Lisa D MarroquinYvonne Will
Apr 7, 2010·European Journal of Medical Research·Jean-Francois Mouscadet, Luba Tchertanov
May 18, 2010·Journal of Bacteriology·Thomas R IoergerJames C Sacchettini
Mar 8, 2011·Bioorganic & Medicinal Chemistry Letters·Deping WangKe Ding
Mar 16, 2011·Current Topics in Medicinal Chemistry·Clifton E Barry
Jul 11, 2013·Respirology : Official Journal of the Asian Pacific Society of Respirology·Chi Chiu LeungYing Zhang
Oct 2, 2013·Annual Review of Genetics·Eduardo A GroismanMauricio H Pontes
Aug 1, 2014·Current Opinion in Microbiology·Pooja Gopal, Thomas Dick
May 8, 2015·Nature Protocols·Lawrence A KelleyMichael J E Sternberg
Nov 26, 2015·The New England Journal of Medicine·C Robert HorsburghChristoph Lange
Aug 26, 2018·Current Opinion in Pharmacology·M Daben J LibardoClifton E Barry

❮ Previous
Next ❯

Citations

Apr 2, 2021·Frontiers in Cellular and Infection Microbiology·Sangmi OhHelena I Boshoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.